|
Research Report
Hotstocked.com has a complete research report available for ACCP stock.
Download ACCP report.
Research Report
Get the full report for FREE
 Access Pharmaceuticals, Inc. (ACCP)
Access Pharmaceuticals, Inc. is a Delaware corporation. We are an emerging biopharmaceutical company developing products for use in the treatment of cancer, the supportive care of cancer, and other disease states. Our product for the management of oral mucositis, MuGard, has received marketing clearance by the FDA as a device. Our lead clinical development program for the drug candidate ProLindac (formerly known as AP5346) is in Phase II clinical testing. Access also has advanced drug delivery technologies including Cobalamin-mediated oral drug delivery and targeted delivery.
READ MORE
Total Income, Quarterly
Profit margin
Net income
Revenue / Net income
Short Term
Long Term
 Accounts payable
Chart
  Other current liabilities
Chart
 Cash and cash equivalents
Chart
  Net receivables
Chart
Other current assets
Chart
  Long term debt
Chart
  Deferred long term liability charges
Chart
  Property plant and equipment
Chart
  Intangible assets
Chart
Other assets
Chart
Short Term
Long Term
Social Bookmarking 
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
